For Immediate Release
Highlights of the latest issue of SLAS Discovery include small molecule cytokine antagonists, a versatile ELISA for PPI inhibitor screening, next-generation CETSA platform, and advances in 3D cell culture.
The latest volume of SLAS Technology demonstrates how artificial intelligence, automation, and portable technologies are reshaping drug discovery, diagnostics and therapeutic development.
The Society for Laboratory Automation and Screening (SLAS) is pleased to announce Lena Landaverde, MS, PhD candidate in the Biomedical Engineering program at Boston University College of Engineering (Boston, MA, USA), as the 2026 SLAS Graduate Education Fellowship Grant recipient.
The Society of Laboratory Automation and Screening has introduced the 12 companies selected for the Innovation AveNEW program at SLAS Europe 2026 Conference and Exhibition, taking place 19-21 May in Vienna, Austria.
Breaking exhibitor and attendance records in Boston, the SLAS hosted 419 exhibitors and more than 7,600 registrants from 47 countries at its 2026 International Conference and Exhibition, February 7-11.
The Society for Laboratory Automation and Screening (SLAS) has been awarded a $199,884 grant from the Alfred P. Sloan Foundation to lead a multi-year initiative to develop education standards for laboratory automation, addressing a growing gap between the rapid adoption of automation technologies and formal training pathways for the scientific workforce.
The Society for Laboratory Automation and Screening (SLAS) is pleased to announce the 2026 honorees of the annual publication awards recognizing articles, authors and reviewers from SLAS Discovery and SLAS Technology.
The Society of Laboratory Automation and Screening (SLAS), announces the appointment of Madeline M. Farley, PhD, as its new Scientific Director, effective January 19.
